The identification of a CD47-blocking "hotspot" and design of a CD47/PD-L1 dual-specific antibody with limited hemagglutination.
Rui ShiYan ChaiXiaomin DuanXiaoshan BiQingrui HuangQihui WangShuguang TanGeorge F GaoJianhua ZhuJinghua YanPublished in: Signal transduction and targeted therapy (2020)
Keyphrases